This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.
Company Filing History:
1 out of 834,411 Years Active: 2001
Title: Sharon Cousin: Innovator in Diabetes Treatment
Introduction
Sharon Cousin is a notable inventor based in Irving, TX (US). She has made significant contributions to the field of diabetes treatment through her innovative research and patented methods. Her work focuses on the role of free radicals in diabetes and offers new strategies for therapeutic interventions.
Latest Patents
Sharon Cousin holds a patent for "Methods and compositions relating to no-mediated cytotoxicity." This invention addresses the treatment of diabetes by demonstrating that manganese superoxide dismutase (MnSOD) can protect against cytokine-induced cell death. The patent outlines methods for engineering cell lines to serve as islet surrogates for transplantation therapy in diabetes mellitus. Additionally, it highlights the role of fatty acids in mediating β-cell destruction and dysfunction in adipogenic diabetes, providing methods and compositions to ameliorate this disorder.
Career Highlights
Throughout her career, Sharon has focused on innovative approaches to diabetes treatment. Her research has contributed to a deeper understanding of the mechanisms involved in diabetes and has paved the way for potential new therapies. With her expertise, she has become a respected figure in her field.
Collaborations
Sharon has collaborated with notable colleagues, including Anice E Thigpen and Hans-Ewald Hohmeier. These partnerships have enhanced her research efforts and contributed to the advancement of diabetes treatment methodologies.
Conclusion
Sharon Cousin's work exemplifies the impact of innovation in the medical field, particularly in diabetes treatment. Her patented methods and compositions represent a significant step forward in addressing this chronic condition.